PeptidePub Blog

Research findings, pricing news, and vendor analysis across the peptide market.

Posts about Semaglutide

Showing 1 to 1 of 1

NewsSeptember 18, 20269 min read

Next GLP-1 Drugs After Zepbound: Retatrutide, CagriSema, Amycretin, CT-388, Mazdutide, and Monthly Shots

The next wave of obesity drugs is moving beyond single GLP-1 therapy toward triple agonists, amylin combinations, oral pills, and longer dosing intervals. Retatrutide has the strongest late-stage weight-loss signal so far, but most pipeline drugs are still investigational and should not be treated as available alternatives to Zepbound.

STOP PIECING IT TOGETHER

One article at a time is a slow way to learn peptides.

We wrote the shortcut: five books, 45 compounds, every claim graded by the strength of the real evidence. No hype, no gatekeeping, and free updates for life whenever the market shifts. Most readers say it replaces months of forum digging.

Get the Handbook30-day money-back guarantee. Free updates for life.